CIK: 0001907884 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $1,565,453 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BEAM | BEAM THERAPEUTICS INC | 937,000 | $25,974 | 1.7% | $25.65 | -0.5% | CALL | 07373V105 |
| BHVN | BIOHAVEN LTD | 702,884 | $7,936 | 0.5% | $12.39 | 0.0% | COM | G1110E107 |
| STRO | SUTRO BIOPHARMA INC | 479,590 | $5,549 | 0.4% | $9.49 | 0.0% | COM SHS | 869367201 |
| OMER | OMEROS CORP | 200,000 | $3,436 | 0.2% | — | — | PUT | 682143102 |
| EVMN | EVOMMUNE INC | 185,482 | $3,175 | 0.2% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| ALEC | ALECTOR INC | 2,000,000 | $3,120 | 0.2% | $1.77 | 0.0% | COM | 014442107 |
| PRLD | PRELUDE THERAPEUTICS INC | 788,867 | $2,288 | 0.1% | $1.69 | 0.0% | COM | 74065P101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CTMX | CYTOMX THERAPEUTICS INC | 8,966,077 (+145.9%) | $38,195 (+228.4%) | 2.4% | $3.02 | +26.0% | COM | 23284F105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,810,954 (+198.8%) | $29,247 (+296.1%) | 1.9% | $13.44 | -1.4% | COM | 483497103 |
| CGEM | CULLINAN THERAPEUTICS INC | 3,114,132 (+35.3%) | $32,231 (+136.1%) | 2.1% | $11.02 | -18.1% | COM | 230031106 |
| APLS | APELLIS PHARMACEUTICALS INC | 908,607 (+12.4%) | $22,824 (+24.7%) | 1.5% | $23.34 | +0.5% | COM | 03753U106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP DEL | 67,588 | $20,010 | 1.3% | $336.31 | +38.5% | — | 91307C102 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 5,466,825 | $7,162 | 0.5% | $6.46 | -59.8% | — | 46333X108 |
| URGN | UROGEN PHARMA LTD | 282,412 | $6,936 | 0.4% | $9.64 | +125.1% | — | M96088105 |
| — | SUTRO BIOPHARMA INC | 5,088,099 | $4,419 | 0.3% | $2.71 | — | — | 869367102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 253,979 | $4,120 | 0.3% | $14.42 | +39.2% | — | 28036F105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 6,165,223 (-21.8%) | $218,989 (+93.4%) | 14.0% | $7.97 | +252.9% | COM | 19240Q201 |
| VERA | VERA THERAPEUTICS INC | 3,433,051 (-14.8%) | $173,850 (+48.5%) | 11.1% | $21.50 | +65.2% | CL A | 92337R101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,470,541 (-66.8%) | $45,763 (-52.1%) | 2.9% | $16.74 | +63.9% | COM | 92790C104 |
| CGON | CG ONCOLOGY INC | 945,830 (-52.8%) | $39,271 (-51.4%) | 2.5% | $34.56 | +19.7% | COM | 156944100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 8,050,959 (-5.5%) | $169,151 (+29.0%) | 10.8% | $17.75 | -1.7% | COM | 87164F105 |
| PCVX | VAXCYTE INC | 2,922,335 (-4.9%) | $134,837 (+21.9%) | 8.6% | $77.50 | -42.3% | COM | 92243G108 |
| ENGN | ENGENE HOLDINGS INC | 1,492,898 (-70.1%) | $13,481 (-60.5%) | 0.9% | $7.65 | +4.7% | COM | 29286M105 |
| NRIX | NURIX THERAPEUTICS INC | 1,970,357 (-9.1%) | $37,378 (+86.5%) | 2.4% | $12.80 | +12.3% | COM | 67080M103 |
| TYRA | TYRA BIOSCIENCES INC | 1,564,492 (-32.9%) | $41,130 (+26.2%) | 2.6% | $13.36 | +37.5% | COM | 90240B106 |
| IMCR | IMMUNOCORE HLDGS PLC | 856,462 (-15.1%) | $29,728 (-18.9%) | 1.9% | $29.77 | — | ADS | 45258D105 |
| BEAM | BEAM THERAPEUTICS INC | 2,440,214 (-3.1%) | $67,643 (+10.7%) | 4.3% | $25.65 | -0.5% | COM | 07373V105 |
| MBX | MBX BIOSCIENCES INC | 934,799 (-53.3%) | $29,484 (-15.8%) | 1.9% | $13.37 | +81.5% | COM | 55287L101 |
| AMRN | AMARIN CORP PLC | 389,273 (-32.4%) | $5,432 (-42.4%) | 0.3% | $16.22 | — | SPONSORED ADR | 023111404 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 5,943,180 (-2.6%) | $161,417 (+2.3%) | 10.3% | $29.50 | -10.7% | COM NEW | 15117B202 |
| WVE | WAVE LIFE SCIENCES LTD | 2,169,105 (-52.4%) | $36,875 (+10.5%) | 2.4% | $4.64 | +119.0% | SHS | Y95308105 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,503,302 (-18.4%) | $3,980 (-44.3%) | 0.3% | $3.41 | -38.5% | COM | 142038108 |
| RLAY | RELAY THERAPEUTICS INC | 1,424,259 (-50.7%) | $12,049 (-20.0%) | 0.8% | $4.42 | +61.6% | COM | 75943R102 |
| TVTX | TRAVERE THERAPEUTICS INC | 517,884 (-45.5%) | $19,788 (-12.8%) | 1.3% | $15.29 | +112.6% | COM | 89422G107 |
| PHVS | PHARVARIS N V | 640,395 (-5.1%) | $17,771 (+5.5%) | 1.1% | $22.18 | +8.6% | COM | N69605108 |
| DSGN | DESIGN THERAPEUTICS INC | 784,606 (-23.8%) | $7,360 (-5.1%) | 0.5% | $4.65 | +68.6% | COM | 25056L103 |
| PRQR | PROQR THRAPEUTICS N V | 1,566,317 (-5.0%) | $3,164 (-9.9%) | 0.2% | $3.18 | -26.4% | SHS EURO | N71542109 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,375,632 (-35.9%) | $21,157 (-0.7%) | 1.4% | $12.15 | — | COM NEW | 268158201 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BNR | BURNING ROCK BIOTECH LTD | 994,883 | $20,047 | 1.3% | $6.40 | — | SPONSORED ADS | 12233L206 |
| CLYM | CLIMB BIO INC | 1,028,341 | $4,113 | 0.3% | $2.66 | -9.9% | COM | 28658R106 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 9,366,526 | $73,059 | 4.7% | $6.82 | +5.9% | COM | 09058V103 |
| GERN | GERON CORP | 3,456,318 | $4,562 | 0.3% | $2.44 | -48.5% | COM | 374163103 |